Sonoma Pharmaceuticals, Inc. (SNOA)
NASDAQ: SNOA · Real-Time Price · USD
4.000
+0.170 (4.44%)
At close: Oct 29, 2025, 4:00 PM EDT
3.918
-0.082 (-2.04%)
After-hours: Oct 29, 2025, 5:03 PM EDT

Sonoma Pharmaceuticals Revenue

Sonoma Pharmaceuticals had revenue of $4.01M in the quarter ending June 30, 2025, with 18.40% growth. This brings the company's revenue in the last twelve months to $14.91M, up 17.43% year-over-year. In the fiscal year ending March 31, 2025, Sonoma Pharmaceuticals had annual revenue of $14.29M with 12.19% growth.

Revenue (ttm)
$14.91M
Revenue Growth
+17.43%
P/S Ratio
0.37
Revenue / Employee
$1,864,000
Employees
8
Market Cap
6.60M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 202514.29M1.55M12.19%
Mar 31, 202412.74M-537.00K-4.05%
Mar 31, 202313.27M644.00K5.10%
Mar 31, 202212.63M-6.00M-32.21%
Mar 31, 202118.63M701.00K3.91%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group435.16B
Johnson & Johnson92.15B
Merck & Co.63.62B
AbbVie58.33B
AstraZeneca56.50B
Novartis AG56.37B
Eli Lilly and Company53.26B
Novo Nordisk49.11B
Revenue Rankings